Cargando…
Adenovirus and Immunotherapy: Advancing Cancer Treatment by Combination
Gene therapy with viral vectors has significantly advanced in the past few decades, with adenovirus being one of the most commonly employed vectors for cancer gene therapy. Adenovirus vectors can be divided into 2 groups: (1) replication-deficient viruses; and (2) replication-competent, oncolytic (O...
Autores principales: | Sato-Dahlman, Mizuho, LaRocca, Christopher J., Yanagiba, Chikako, Yamamoto, Masato |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281656/ https://www.ncbi.nlm.nih.gov/pubmed/32455560 http://dx.doi.org/10.3390/cancers12051295 |
Ejemplares similares
-
Mutant myogenin promoter-controlled oncolytic adenovirus selectively kills PAX3-FOXO1-positive rhabdomyosarcoma cells
por: Yoshida, Hideki, et al.
Publicado: (2020) -
The Role of Adenovirus in Cancer Therapy
por: Sato-Dahlman, Mizuho, et al.
Publicado: (2020) -
Showing the Way: Oncolytic Adenoviruses as Chaperones of Immunostimulatory Adjuncts
por: Huang, Jing Li, et al.
Publicado: (2016) -
Combination of interferon-expressing oncolytic adenovirus with chemotherapy and radiation is highly synergistic in hamster model of pancreatic cancer
por: Salzwedel, Amanda O., et al.
Publicado: (2018) -
CD133-targeted oncolytic adenovirus demonstrates anti-tumor effect in colorectal cancer
por: Sato-Dahlman, Mizuho, et al.
Publicado: (2017)